# Graduate Training in the Pharmacological Sciences

> **NIH NIH T32** · EMORY UNIVERSITY · 2020 · $289,234

## Abstract

Project Summary
 Modern drug discovery and development require the training of scientists who understand the
molecular, physiological and quantitative basis of drug action and specificity, and who can apply modern
technologies and concepts to the development of novel therapeutic strategies. This multidisciplinary doctoral
training program in the Pharmacological Sciences is designed to help meet that demand by preparing students
for biomedical research careers in schools of medicine, dentistry and pharmacy, in research institutes, and in
governmental or industrial laboratories. The most important component of training is laboratory research, first
as a series of research rotations, then in the dissertation laboratory. This training is complemented by a core
course that integrates the theoretical and experimental foundations of modern biological sciences; core
courses in pharmacology that emphasize quantitative analysis of drug action, pharmacokinetics, drug
disposition, biostatistics and experimental design; advanced courses in specialty areas; seminar courses and
journal clubs. Emphasis throughout is placed on development and refinement of communication and analytical
skills. The 52 training faculty members represent 17 basic science and clinical departments at Emory, thereby
providing a wealth of diverse research training opportunities. Research foci in the program include
Neurological Diseases & Therapy, Cancer Pharmacology, Cardiovascular Pharmacology, Chemical Biology &
Drug Discovery, and Novel Therapeutic Modalities. Cell Signaling, Systems & Integrative Pharmacology, and
Toxicology are crosscutting themes. This Program currently supports six students each year, who are selected
mainly from a pool of approximately 20-30 eligible students in the first three years of the Molecular and
Systems Pharmacology (MSP) Program. Six slots are requested in this renewal. Graduates will have acquired
broad familiarity with pharmacology, deep knowledge in the area of dissertation research, and the technical,
communicative and analytical skills necessary to pursue an independent research career. The research
conducted by the trainees in this program will advance our knowledge of disease processes and contribute to
development of novel and improved therapeutic strategies that will benefit the health of our citizens. By
preparing young scientists to contribute to and lead the nation's efforts in these areas, this training program will
help to ensure that our ability to improve the nation's health remains strong in the future.

## Key facts

- **NIH application ID:** 9939565
- **Project number:** 5T32GM008602-24
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Randy A. Hall
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $289,234
- **Award type:** 5
- **Project period:** 1996-07-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9939565

## Citation

> US National Institutes of Health, RePORTER application 9939565, Graduate Training in the Pharmacological Sciences (5T32GM008602-24). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9939565. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*